• Exchange: Mexico
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AMGN*:MM

1,567.70 MXN 5.00 0.32%

As of 16:08:59 ET on 07/08/2014.

Snapshot for Amgen Inc (AMGN*)

Open: 1,567.70 Day's Range: 1,567.70 - 1,567.70 Volume: 3,030
Previous Close: 1,562.70 52wk Range: 1,309.70 - 1,685.60 1-Yr Rtn: +21.73%

Stock Chart for AMGN*

No chart data available.
  • AMGN*:MM 1,567.70
  • 1D
  • 1M
  • 1Y
1,562.70
Interactive AMGN* Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMGN*

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 14.9133
Relative P/E vs. MEXBOL -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 8.0950
Est. PEG Ratio 1.9039
Market Cap (M MXN) 1,186,782.84
Shares Outstanding (M) 757.02
30 Day Average Volume 738
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.01%
Cash Dividend (USD) 0.6100
Dividend Ex-Date 05/13/2014
5 Year Dividend Growth -
Next Earnings Announcement 07/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMGN*

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMGN*

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Robert A Bradway "Bob"Chairman/President/CEOAnthony C Hooper "Tony"Exec VP:Global Commercial Ops
Brian M McNameeExec VP:Full Potential InitiativesMadhavan BalachandranExec VP:Operations
More Company Profile & Key Executives for AMGN*

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil